½ÃÀ庸°í¼­
»óǰÄÚµå
1468244

´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ½ÃÀå º¸°í¼­ : À¯Çü, Á¦Ç° ÇüÅÂ, ¿ëµµ, Áö¿ªº°(2024-2032³â)

Protein Hydrolysate Ingredient Market Report by Type, Product Form, Application, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 135 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ½ÃÀå ±Ô¸ð´Â 2023³â 35¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀåÀÌ 2024-2032³â »çÀÌ 4.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î 2032³â±îÁö 52¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á´Â ¾Æ¹Ì³ë»ê, ÆéŸÀÌµå ¹× ¿Ã¸®°í ÆéŸÀ̵带 Æ÷ÇÔÇÏ´Â °íµµ·Î Á¤Á¦ µÈ ´Ü¹éÁúÀÇ È¥ÇÕ¹°·Î ºÎºÐ ¶Ç´Â ¿ÏÀü °¡¼ö ºÐÇØ¿¡ ÀÇÇØ ¾ÐÂøµË´Ï´Ù. ¶ÇÇÑ ºÐÁö »ç½½ ¾Æ¹Ì³ë»ê, À̼ҷù½Å, ¹ß¸°, ·ù½Åµµ Æ÷ÇԵǾî ÀÖ¾î ±ÙÀ°À» ¸¸µé°í À¯ÁöÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿ìÀ¯, Ä«Á¦ÀÎ, À°·ù µîÀÌ ÀϹÝÀûÀÎ Á¦Ç° À¯ÇüÀÔ´Ï´Ù. ´Ü¹éÁú °¡¼öºÐÇØ¹° ¼ººÐÀº õ½Ä, À½½Ä ¾Ë·¹¸£±â, ¿µ¾ç½ÇÁ¶, ½ÀÁø µî ¼Ò¾Æ°ú ÁúȯÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ Ç×±Õ, Ç×°íÇ÷¾Ð, Ç×»êÈ­, ¸é¿ª Ȱ¼ºÈ­, Ç×Ç÷Àü, Ç×´ç´¢º´ È¿°úµµ ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÌ ¼ººÐÀº ½ºÆ÷Ã÷ ¿µ¾ç, À¯¾Æ¿ë Á¶Á¦ºÐÀ¯, ±â´É¼º ½Äǰ¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ½ÃÀå µ¿Çâ:

Àü ¼¼°è ´ëÁßÀÇ °Ç°­ ÀǽÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®´ÙÁÖ°í ÀÖ½À´Ï´Ù. ´Ü¹éÁúÀ» Á¤±âÀûÀ¸·Î ¼·ÃëÇÏ¸é »õ·Î¿î ¼¼Æ÷¸¦ ¸¸µé°í, ¼Õ»óµÈ Á¶Á÷À» º¹±¸Çϰí, ±ÙÀ° ¼¼Æ÷¸¦ ¹ß´Þ½ÃŰ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ °¡±Ý·ù, ¾î·ù, µÅÁö ¹× ¹Ý·Áµ¿¹°ÀÇ »ç·á Á¦Á¶¿¡ ´Ü¹éÁú °¡¼öºÐÇØ¹°ÀÌ ³Î¸® »ç¿ëµÇ´Â °ÍÀº µ¿¹°ÀÇ Àü¹ÝÀûÀÎ °Ç°­ ÁõÁø¿¡ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ¶Ç ´Ù¸¥ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ³ôÀº ¿µ¾ç°¡, ½¬¿î ¼ÒÈ­¼º, ºü¸¥ ȸº¹, üÁß Á¶Àý¿¡ µµ¿òÀ» ÁÖ´Â À¯Ã» ´Ü¹éÁú °¡¼öºÐÇØ¹°ÀÇ µµÀÔÀº ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ±ú²ýÇÑ ½Ä´Ü, ģȯ°æ ¹× Áö¼Ó°¡´É¼ºÀ» ÃËÁøÇÏ´Â ¿ÏµÎÄá, ½Ò, ½Ò, ´ë¸¶, Äá°ú °°Àº ÀüÅëÀûÀÎ ½Äǰ¿¡¼­ »ý»êµÇ´Â ½Ä¹°¼º ´Ü¹éÁú °¡¼öºÐÇØ¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÙÀ° ȸº¹°ú ±Ù·ÂÀ» Çâ»ó½ÃŰ°í °Ý·ÄÇÑ ¿îµ¿ ¼¼¼Ç µ¿¾È Á¦Áö¹æ üÁßÀ» À¯ÁöÇÏ´Â ½ºÆ÷Ã÷ ¿µ¾ç ¹× ´ÙÀÌ¾îÆ® ½Äǰ¿¡ ´ëÇÑ Á¦Ç° ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾î¸°À̵éÀÇ À¯´çºÒ³»Áõ°ú À§Àå Àå¾Ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó À¯¾Æ¿ë Á¶Á¦ºÐÀ¯ Á¦Ç° äÅÃÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¹Û¿¡µµ ¼ÒºñÀÚÀÇ ¼Òºñ ¿©·Â Áõ°¡¿Í Á¦Ç°ÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´äÇÏ´Â ÁÖ¿ä Áú¹®

  • 2023³â ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ¼¼°è ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â ¼¼°è ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ¼¼°è ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • COVID-19°¡ ¼¼°è ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ¼¼°è ½ÃÀå¿¡¼­ ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·áÀÇ Á¾·ùº° ºÐ·ù´Â?
  • Á¦Ç° ÇüÅ¿¡ µû¸¥ ´Ü¹éÁú °¡¼öºÐÇØ¹° ¼ººÐ ¼¼°è ½ÃÀå ÇöȲÀº?
  • ¿ëµµ¿¡ µû¸¥ ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ¼¼°è ½ÃÀå ÇöȲÀº?
  • ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ¼¼°è ½ÃÀå¿¡¼­ ÁÖ¿ä Áö¿ªÀº?
  • ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ¼¼°è ½ÃÀå¿¡¼­ ÁÖ¿ä Ç÷¹À̾î/±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ´Ü¹éÁú °¡¼öºÐÇØ¹° ¿ø·á ¼¼°è ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : À¯Çüº°

  • À¯´Ü¹éÁú °¡¼öºÐÇØ¹°
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • À¯Ã»
      • Æ÷Àå
    • ½ÃÀå ¿¹Ãø
  • ½Ä¹°¼º ´Ü¹éÁú °¡¼öºÐÇØ¹°
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • ´ëµÎ
      • ±âŸ
    • ½ÃÀå ¿¹Ãø
  • µ¿¹°¼º ´Ü¹éÁú °¡¼öºÐÇØ¹°
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : Á¦Ç° Çüź°

  • ºÐ¸»
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¾×ü
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¹Ù
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • À¯¾Æ¿ë Á¶Á¦ºÐÀ¯
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½ºÆ÷Ã÷ ¿µ¾ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀÓ»ó ¿µ¾ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï »óȲ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • A. Costantino & C. spa
    • Abbott Laboratories
    • Agropur Cooperative
    • AMCO Proteins
    • Arla Foods amba
    • Armor Proteines(Savencia Fromage & Dairy)
    • Carbery Group Limited
    • Fonterra Co-operative Group Limited
    • Glanbia PLC
    • Hilmar Ingredients
    • Kerry Group plc
    • Milk Specialties Global
    • Nestle S.A.
    • Royal FrieslandCampina N.V.(Zuivelcooperatie FrieslandCampina U.A.)
ksm 24.05.13

The global protein hydrolysate ingredient market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032.

Protein hydrolysate ingredients are a mixture of a highly purified form of proteins containing amino acids, peptides, and oligopeptides that are pressed by partial or complete hydrolysis. They also include branched-chain amino acids, isoleucine, valine, and leucine, which play a critical role in building and maintaining muscles. Milk, casein, and meat are some common product types. Protein hydrolysate ingredients assist in reducing several pediatric conditions, such as asthma, food allergies, malnutrition, and eczema. They also exhibit antimicrobial, antihypertensive, antioxidant, immunostimulatory, antithrombotic, and anti-diabetic properties. As a result, these ingredients are widely used in sports nutrition, infant formulas, and functional food products.

Protein Hydrolysate Ingredient Market Trends:

The rising health consciousness among the masses across the globe is creating a positive outlook for the market. Regular protein consumption helps build new cells, fix damaged tissues, and develop muscle cells. Additionally, the widespread utilization of protein hydrolysate for preparing diets for poultry, fish, pigs, and companion animals, as they help enhance the overall health of the animal, is acting as another growth-inducing factor. Apart from this, the introduction of whey protein hydrolysates that offer high nutritional value, easy digestibility, faster recovery, and aid in weight management is providing an impetus to the market growth. In line with this, the increasing demand for plant-based protein hydrolysate manufactured from old standbys, including pea, rice, hemp, and soy, that promotes clean eating, environmental friendliness, and sustainability are propelling the market growth. Furthermore, the increasing product demand for sports nutrition and diet food products that improve muscle recovery and strength and maintain lean muscle mass during intense training sessions is positively influencing the market growth. Besides this, the widespread product adoption for infant formulas, due to the increasing lactose intolerance and gastrointestinal disorders in children, is supporting the market growth. Other factors, including the rising expenditure capacities of consumers and the increasing awareness about product benefits, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global protein hydrolysate ingredient market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product form and application.

Breakup by Type:

Milk Protein Hydrolysate

Whey

Caesin

Plant Protein Hydrolysate

Soy

Others

Animal Protein Hydrolysate

Breakup by Product Form:

Powder

Liquid

Bar

Breakup by Application:

Infant Formula

Sports Nutrition

Clinical Nutrition

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Costantino & C. spa, Abbott Laboratories, Agropur Cooperative, AMCO Proteins, Arla Foods amba, Armor Proteines (Savencia Fromage & Dairy), Carbery Group Limited, Fonterra Co-operative Group Limited, Glanbia PLC, Hilmar Ingredients, Kerry Group plc, Milk Specialties Global, Nestle S.A. and Royal FrieslandCampina N.V. (Zuivelcooperatie FrieslandCampina U.A.).

Key Questions Answered in This Report

  • 1. What was the size of the global protein hydrolysate ingredient market in 2023?
  • 2. What is the expected growth rate of the global protein hydrolysate ingredient market during 2024-2032?
  • 3. What are the key factors driving the global protein hydrolysate ingredient market?
  • 4. What has been the impact of COVID-19 on the global protein hydrolysate ingredient market?
  • 5. What is the breakup of the global protein hydrolysate ingredient market based on the type?
  • 6. What is the breakup of the global protein hydrolysate ingredient market based on the product form?
  • 7. What is the breakup of the global protein hydrolysate ingredient market based on the application?
  • 8. What are the key regions in the global protein hydrolysate ingredient market?
  • 9. Who are the key players/companies in the global protein hydrolysate ingredient market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Protein Hydrolysate Ingredient Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Milk Protein Hydrolysate
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Whey
      • 6.1.2.2 Caesin
    • 6.1.3 Market Forecast
  • 6.2 Plant Protein Hydrolysate
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Soy
      • 6.2.2.2 Others
    • 6.2.3 Market Forecast
  • 6.3 Animal Protein Hydrolysate
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product Form

  • 7.1 Powder
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Liquid
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Bar
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infant Formula
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Sports Nutrition
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Nutrition
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 A. Costantino & C. spa
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agropur Cooperative
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 AMCO Proteins
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Arla Foods amba
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Armor Proteines (Savencia Fromage & Dairy)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Carbery Group Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Fonterra Co-operative Group Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Glanbia PLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Hilmar Ingredients
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Kerry Group plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Milk Specialties Global
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Nestle S.A.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14 Royal FrieslandCampina N.V. (Zuivelcooperatie FrieslandCampina U.A.)
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦